Furthermore, we discovered that CUEDC2 exerted its anti-AML roles via attenuated ubiquitin- mediated degradation of SOCS1 by enhancing interactions among SOCS1, Elongin C and CUL2. The gene discussed is SOCS1; the disease is acute myeloid leukemia.